NuVasive (NUVA) announced that at the special meeting of shareholders held earlier today, its shareholders voted to approve the adoption of the company’s merger agreement with Globus Medical (GMED). As previously announced, under the terms of the merger agreement, NuVasive shareholders will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive common stock owned at the closing of the transaction. "We appreciate our shareholders’ strong support for NuVasive’s combination with Globus Medical," said Chris Barry, CEO of NuVasive. "We look forward to closing the transaction and realizing the significant benefits created by joining our more than 5,000 employees, geographic footprints, highly complementary innovations, customer bases and leading portfolios." Globus Medical is holding a separate special meeting of shareholders later today to vote on the issuance of Globus Medical shares to NuVasive shareholders in connection with the transaction.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on NUVA:
- NuVasive Shareholders Approve Merger Agreement with Globus Medical
- NuVasive says Glass Lewis recommends shareholders vote for Globus merger
- Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending NuVasive Shareholders Vote “FOR” the Proposed Merger with Globus Medical
- TD Cowen medical devices analyst to hold analyst/industry conference call
- Leading Independent Proxy Advisory Firm ISS Recommends NuVasive Shareholders Vote “FOR” the Proposed Merger with Globus Medical
